Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Slides:



Advertisements
Similar presentations
Diabetes Self Management Laura Wintersteen-Arleth, MN, RN,CDE
Advertisements

Optimizing Diabetic Care in Residential Care
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Diabetes Prevention.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Diabetes in Pregnancy Screening.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,
Competitive Grant Program Core Elements Evaluation Overview Yvette Roubideaux, MD, MPH.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 3 SDPI Healthy Heart Project.
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.
SDPI Competitive Grant Program Planning Meeting 1 IHS Diabetes Competitive Grant Program: Overview and Update Kelly Acton, MD, MPH, FACP Director, IHS.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
Core Elements.  Recruitment Goals = 48 new participants each year  Recruitment for Intensive Activities 1. Recruitment Team 2. Team Meetings  Invitation.
Screening and Eligibility for DPP Clinical Guidelines.
Core Elements: Case Management Recruitment Yvette Roubideaux, MD, MPH.
Core Elements: DPP Curriculum DP Recruitment Yvette Roubideaux, MD, MPH.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
CVD Risk Reduction Group Screening and Eligibility Core Elements Draft July 2005.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
The Diabetes Prevention Program A U.S. Randomized Clinical Trial to Prevent Type 2 Diabetes in Persons at High Risk.
Title slide Include name of program and logo here Reference program as part of the National Diabetes Prevention Program led by CDC.
I CAN Prevent Diabetes! Individuals and Communities Acting Now to Prevent Diabetes Recruitment Discussion 2012.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Critical evaluation of the diagnosis of Gestational Diabetes Mellitus (GDM) Simon Weitzman, MD, MPH.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Prediabetes Burden.
Prediabetes Screening and Monitoring 1. Rationale for Prediabetes Screening Epidemiologic evidence suggests the complications of diabetes begin early.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
1 Presenter Disclosure Information FINANCIAL DISCLOSURE: DSMB’s: Merck, Takeda Barry R. Davis, MD, PhD Clinical Outcomes in Participants with Dysmetabolic.
Screening and Eligibility for DPP Clinical Guidelines Presentation: Screening & Eligibility Klamath Tribe.
DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
Integration of 5 Public Health Programs Jan Norman, RD, CDE Chronic Disease Prevention Unit Washington State Department of Health.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Designing Screening Protocols for Diabetes and Pre-diabetes Ron Horswell, PhD (PBRC) Gang Hu, MD PhD (PBRC) Study group: Jolene Johnson, MD (LSU HSC) Will.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Diabetes National Diabetes Control Programme
Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.
Categories of disease Genetic (born with – even if disease doesn’t develop till later in life) Infectious – Virus and bacterial Environmental / Self-inflicted.
Pre-diabetes: Risk Factors & Diagnosis Saoirse Ní Chuirrín DNS Caitriona Lordan Dietitian September 2015.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
A two stage screening process – the pre-diabetes pathway.
DIABETES CASE PRESENTATIONS 1 st - diagnosis. Case 1 Male, 24 yrs old Male, 24 yrs old Presents in the ER for nausea, vomiting, abdominal pain, shortness.
Screening for Diabetes in Pregnancy
A Study on Gestational Diabetes in Eastern India
Diabetes Health Status Report
Screening and Monitoring
Screening and Monitoring
Screening for Diabetes in Pregnancy
Prediabetes Burden.
دیابت سالمندان دکتر میترا مرادی نیا.
Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.
Presentation transcript:

Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention

Overview Diagnosis of Prediabetes Screening Strategies Draft Core Elements for Screening Grantee Panel Discussion Questions/Discussion

Prediabetes  Definition Individuals with abnormal glucose regulation intermediate between the normal state and the state of diabetes Impaired Fasting Glucose (IFG) Impaired Glucose Tolerance (IGT) Importance of detection Each year, percent develop diabetes Research: Lifestyle changes can reduce risk of developing diabetes

Prediabetes  Detection and treatment will also: Identify undiagnosed diabetes in some individuals Identify undiagnosed hypertension and undiagnosed dyslipidemias in some patients Lay the groundwork for healthy lifestyle changes

Stages in the natural history of diabetes NormalIGT Type 2 Diabetes Complications Disability Death Genetic Predisposition Preclinical StateClinical diseaseComplicationsDeath Disability Primary Prevention Secondary Prevention Tertiary Prevention

Diagnosis of Prediabetes  Classification and Tests Impaired Fasting Glucose (IFG) Fasting Blood Glucose (FBG)100 – 125 Impaired Glucose Tolerance (IGT) 2 hour Oral Glucose Tolerance Test (OGTT)

Comparison of Test Results TestNormalPrediabetesDiabetes FBG (mg/dl) < (IFG) >125 OGTT – 2hr result (mg/dl) < (IGT) ≥ 200

Overlap of IGT and IFG Both IFG IGT

Screening for Prediabetes  Targeted vs. Universal Screening Targeted Screening more cost effective Universal Screening not routinely recommended Screen individuals 18 years and older with risk factors for Prediabetes or Metabolic Syndrome Overweight, Obesity Hypertension Low HDL, high TG Women with a history of GDM Family history of diabetes

Screening for Prediabetes  In practice, several strategies: Community settings Strategies include: Paper risk tests Fingerstick glucose tests Importance of Follow-up Clinical settings Random blood glucose Fasting blood glucose 2 hr Oral Glucose Tolerance Test

CGP Considerations  Eligibility for Intensive Activities Prediabetes – IFG, IGT Consistent with DPP, other studies Metabolic Syndrome – may consider eligibility later in demonstration project Screening Activities Opportunity to see what works, lessons learned Potential benefits for other Indian health programs

Core Element: Screening  Draft Protocol/Required Elements Developed in context of: IHS Prediabetes Guidelines Informal grantee input at previous meetings Discussion with technical experts IHS DDTP recommendations Target screening of individuals with risk factors Possible Settings for Screening Community Clinical Setting

Core Element: Screening  Community Screening Assessment of Risk Paper Risk Test, AND Fingerstick Glucose If either positive Refer to clinic OGTT – results include both FBG and 2 hr value FBG alone not enough – may miss some with undiagnosed diabetes Possible evaluation activity Compare use of paper risk test, fingerstick glucose, FBG, OGTT May result in lessons learned for other Indian health programs

Core Element: Screening  Outcomes of screening Normal results Education on risks for diabetes Prediabetes (IFG or IGT) Recruit to enter Intensive Activities Diabetes Refer to clinic for further care

Next Steps  Draft protocol/required activities Handout for binder Discuss with team  Grantee panel discussion Experience with screening for prediabetes  Questions/Discussion/Input All grant programs